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1160Objective: The objective of the present study was to determine the long-term fate and factors of compensatory
hyperhidrosis (CH) in patients who have undergone video-assisted thoracoscopic sympathotomy for focal
hyperhidrosis.
Methods: The same quality-of-life survey was administered 6 months postoperatively and then annually to all
patients who underwent video-assisted thoracoscopic sympathotomy for hyperhidrosis. A second rib (R2)/R3
sympathotomy was most commonly performed until September 2007 and then R4/R5 sympathotomy was used.
Results: From January 1999 until December 2012, 193 patients underwent video-assisted thoracoscopic sym-
pathotomy for hyperhidrosis, of whom, 173 had provided1 year of postoperative survey information. No oper-
ative mortalities occurred. Of the 173 patients, 133 (77%) reported ‘‘clinically bothersome’’ CH. This rate had
decreased to an average of 35% at 5 and 12 years postoperatively. Univariate analysis showed the CH incidence
was significantly greater for the patients who had undergone R2/R3 versus R4/R5 sympathotomy (P<.001), had
had multiple sites of sweating at presentation (P< .001), had used oral medication to control hyperhidrosis
preoperatively (P ¼ .022), or were female (P ¼ .002). On multivariate analysis, only R2/R3 versus R4/R5
sympathotomy (P< .021) and multiple sites of sweating at presentation (P< .037) remained statistically
significant. Twelve patients (6.2%) regretted having the operation for CH.
Conclusions: Patients who undergo sympathotomy for hyperhidrosis will commonly report ‘‘clinically bother-
some’’ compensatory hyperhidrosis. CH will more likely if R2/R3 sympathetic interruption has been performed
instead of R4/R5 and in patients who present with multiple areas of sweating. The severity of clinically
bothersome CH decreased during the first 3 years postoperatively. (J Thorac Cardiovasc Surg 2014;147:1160-3)Supplemental material is available online.
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Video-assisted thoracoscopic (VATS) sympathotomy is the
treatment of choice for focal hyperhidrosis because of
outstanding and permanent results compared with other
treatment options.1,2 However, the long-term patient satis-
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The Journal of Thoracic and Cardiovascular Surhyperhidrosis several years after surgery is not well known.
The primary objective of the present study was to determine
the long-term effects and temporal trends on the quality of
life, degree of compensatory hyperhidrosis (CH), and fac-
tors predicting CH in patients who have undergone VATS
sympathotomy for focal hyperhidrosis.
METHODS
The present study was a prospective cohort study of patients who had
undergone VATS sympathotomy for hyperhidrosis. The indications for sur-
gery were as previously described.3 Patients with hyperthyroidism, obesity,
and/or generalized full body sweating were not offered surgery.
Operative Technique
General anesthesia was used for all patients. The patient is positioned in
the operating room and prepped and draped only 1 time so we have access
to both areas near each breast without having to reprep and drape. From
1999 to 2007, in general, we used the single 5-mm incision per side tech-
nique that features the interruption of the sympathetic chain on top of the
second (R2) and third (R3) rib using cautery. No chest tube was used,
but the patients were admitted overnight for observation until 2005. Start-
ing in January 2006, the procedure was commonly performed as an outpa-
tient operation. Starting in October 2007, we changed our operative
technique and commonly used an R4/R5 interruption of the sympathetic
chain for most patients. The impetus for this change was based on our
involvement in an expert consensus report.3 In general, we then performed
the interruption according to the patient’s complaint of hyperhidrosis. An
R4 sympathotomy was used for palmar only and R4/R5 for those with
palmar and axilla, palmar, axillar, and pedal, and axillary only. R3 sympa-
thotomy was used for craniofacial hyperhidrosis.gery c April 2014
Abbreviations and Acronyms
CH ¼ compensatory hyperhidrosis
IRB ¼ institutional review board
R# ¼ rib number
UAB ¼ University of Alabama at Birmingham
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The patientswere seen in our clinic 3weeks postoperatively. At that visit,
their satisfactionwith the operation and their level of CHwas assessed; how-
ever, no formal survey was given. The patients were subsequently asked to
participate in a written survey at 6 and 12 months postoperatively and then
annually (Appendix E1). The follow-up data were obtained through surveys
and, if applicable, through office visits and telephone calls. The patients
were contacted through mail and/or e-mail primarily. The percentage of
patients who reported their CH rate was tabulated for each year.
Definitions
We have reported the failure and recurrence rates for the hands, axilla,
and feet. A ‘‘failure’’ was defined as a patient who had never achieved satis-
factory dryness of a specific part of their body that was initially hyperhi-
drotic preoperatively. ‘‘Recurrence’’ was defined as a body part that had
been initially wet that had been rendered dry after surgery and then at
some point had become hyperhidrotic again. We separated CH into several
different categories according to the patients’ response to ‘‘Do you have
any new areas of sweating on your body, and, if so, where is it located,
and rate it on a scale of 1 to 10.’’
1. No CH: if patients responded ‘‘no’’
2. CH: if patients responded ‘‘yes’’
The patients responding ‘‘yes’’ were asked to list the areas of sweating
and to grade each area on a scale of 1 (minimal, infrequent sweating) to 10
(maximal sweating). ‘‘Clinically bothersome’’ CH was defined as a rating
of 5.
The institutional review board (IRB) of the University of Alabama at
Birmingham (UAB) approved the present protocol and the prospective
database used to collect the information for our study. Patient consent
was waived for inclusion in the study; however it was required and obtained
to enter the patient data into the prospective database. The UAB IRB
approved our prospective database (UAB-IRB no. X021104003) and the
hyperhidrosis survey (UAB-IRB no. X021104003). Permission was also
obtained to include patients<18 years old.
Data analysis was performed using Statistical Analysis Systems, version
9.1 (SAS Institute, Cary, NC). Descriptive statistics were used to provide
the frequency and median values of the study variables. Fisher’s exact
test or Pearson’s chi-square test was used to assess the categorical data
and the Wilcoxon test to evaluate the continuous variables. Variables
with P .1 in the univariate model were considered to be possible indepen-
dent variables and were subsequently entered into a stepwise multivariate
regression analysis. The P values were all 2-sided.RESULTS
From January 1999 until December 2012, 193 patients un-
derwent VATS sympathotomy. The patient characteristics are
listed in Table 1.Only 173 patients had undergone surgery1
years earlier and responded to the survey. Three patients who
had undergone R2-only interruption were considered to have
undergone R2/R3 for statistical purposes, and 8 patients whoThe Journal of Thoracic and Carhad undergone R4-only interruption were considered to have
undergoneR4/R5.AfterOctober 10, 2007, only 3 patients un-
derwent an R2/R3 interruption, and they had all had palmar
and cranial facial sweating only. No patients experienced
symptomatic bradycardia orHorner syndrome or complained
of an inability to exercise. A radiographic pneumothorax was
observed in 67%of the patients immediately postoperatively;
however, only 1 patient required a chest tube for the pneumo-
thorax. The median length of hospital stay was 2 days for the
first 83 patients. It was 1 day (hospitalized for the day of
surgery only) for the last 110 patients, all of whom had had
it performed as an outpatient procedure.
The median follow-up period was 6.9 years (range, 6
months to 12 years). The failure and recurrence rates
were the greatest for patients who complained of axillary
and pedal hyperhidrosis (Table 2). Ninety-six patients
described their quality of life as ‘‘very poor’’ or ‘‘poor’’
before the sympathotomy. Of these patients, we obtained
surveys at 5 years for 61 of these patients, and 79% reported
an improvement in their quality of life (described as ‘‘excel-
lent,’’ ‘‘very good,’’ or ‘‘good’’) 1 year after surgery, 85% at
3 years after surgery, and 89% at 5 years after surgery.
Compensatory Hyperhidrosis
At 6 months to 5 years postoperatively, clinically bother-
some CH was reported in a median of 52% of patients. At 1
year postoperatively, clinically bothersome CH was re-
ported by 77% of the patients surveyed (Figure 1). At 5
years after surgery, CH was reported by a median of 37%
of patients. The rate of bothersome CH decreased most
significantly from 1 to 2 years postoperatively. After 3
years, the rate of bothersome CH had also decreased, but
this difference was not significantly different. The most
common sites of ‘‘new’’ (compensatory sweating) reported
were on the back, lower abdomen, and/or groin. Finally, 12
patients (6.2%) regretted having undergone the operation
(secondary to clinically bothersome CH for all 12).
Results of the univariate analysis at 1 year of follow-up
are listed in Table 3. Univariate analysis showed that clini-
cally bothersome CH was significantly greater for patients
who had undergone R2/R3 sympathotomy than for those
who had undergone R4/R5 sympathotomy (P<.001), had
had multiple sites of sweating at presentation (P< .001),
had used an oral prescription for sweating preoperatively
(P¼ .022), or were female (P¼ .002). Onmultivariate anal-
ysis, only the level of interruption (P ¼ .021) and multiple
sweating sites present preoperatively (P ¼ .037) remained
significantly associated with clinically bothersome CH.
DISCUSSION
When a surgeon operates on a patient for lifestyle rea-
sons, the operation must be extremely safe and offer
outstanding short- and long-term results. Although
hyperhidrosis can have severe psychological anddiovascular Surgery c Volume 147, Number 4 1161
TABLE 1. Patient characteristics (n ¼ 193)
Characteristic
Total patients
(n ¼ 193)
Study Population
(1 y postoperatively;
n ¼ 173)
Median age at
operation (y)
25.2 25
Gender
Female 151 (78) 143 (83)
Male 42 (22) 30 (17)
Initially reported
site of HH
Single site 56 (29) 45 (26)
Hands 29 26
Axillary 13 10
Craniofacial 6 4
Feet 8 5
Multiple sites 137 (71) 128 (74)
Hands þ axilla 18 16
Hands þ feet 49 45
Hands þ feet þ axilla 68 65
Other combinations 2 2
Age at onset (y) 12 (preadolescence) 12 (preadolescence)
Median body mass
index (kg/m2)
22.1 23.0
Level of interruption
R2-R3 124 (64.2) 112 (64)
R4-R5 69 (35.8) 61 (35)
Data presented as n (%), unless otherwise noted. HH, Hyperhidrosis; R#, rib number.
FIGURE 1. Percentage of patients with clinically bothersome compensa-
tory hyperhidrosis stratified by postoperative year. *Cumulative results
provided for postoperative years 5 to 12.
TABLE 3. Univariate analysis of 173 patients who responded to the 1-
year survey
Variable
Patients
with clinically
bothersome
CH (n ¼ 133)
Patients
without clinically
bothersome
CH (n ¼ 40) P value
Median age at
surgery (y)
23.2 24.6 .595
Gender .002
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ized), the operation is for lifestyle changes only. For these
reasons, wemust carefully assess not only the short-term re-
sults, but also the long-term results of VATS sympathotomy.
In the present report, we have shown that the long-term
results of VATS sympathotomy for hyperhidrosis were quite
good; however, the rate of CH was high. The published data
have indicated a CH rate of 3% to 98%.4,5 This wide
variation in reported CH rates has primarily resulted from
the different definitions of CH and its inherent
subjectivity. In the present study, we used patient self-
report of their degree of hyperhidrosis. Those who reportedTABLE 2. Failure and recurrence rates of VATS sympathotomy
stratified by patient hyperhidrosis locations
Hyperhidrosis location
preoperatively Failure rate (%) Recurrence rate (%)
Hands only (n ¼ 29
patients)
3.4 (1 patient)* 0
Hands þ axilla (n ¼ 18
patients)
Hands, 0
Axilla, 11 (2 patients)
Hands, 5.6 (1 patient)
Axilla, 11 (2 patients)
Hands þ feet (n ¼ 49
patients)
Hands, 2 (1 patient)*
Feet, 4 (2 patients)
Hands, 0
Feet, 6.1 (3 patients)
Hands þ feet þ axilla
(n ¼ 68 patients)
Hands, 0
Axilla, 4.4 (3 patients)
Feet, 2.9 (2 patients)
Hands, 1.5 (1 patient)
Axilla, 8.8 (6 patients)
Feet, 4.4 (3 patients)
*Treated with reoperation.
1162 The Journal of Thoracic and Cardiovascular Sura5 in a new area of hyperhidrosis were considered to have
clinically bothersome CH. The present study is the first to
show that CH will diminish over time. The reasons are un-
known. However, possible explanation include that the
perception of an illness changes as the person ages or
perhaps a response bias was present in that patients with
CH might have been likely to respond to the survey over
time. We reported a disappointing patient regret rate ofFemale 117 (88) 26 (65)
Male 16 (12) 14 (35)
Initial reported
site of HH
<.001
Single 24 (18) 21 (53)
Multiple 109 (82) 19 (47)
Median BMI (kg/m2) 23.0 24.4 .415
Used oral medication
to control sweating
preoperatively
46 (35) 6 (15) .030
Family history of HH 36 (21) 10 (18) .791
Level of interruption <.001
R2-R3 98 (74) 14 (35)
R4-R5 34 (26) 27 (65)
Data presented as n (%), unless noted otherwise. CH, Compensatory hyperhidrosis;
BMI, body mass index; HH, hyperhidrosis; R#, rib number.
gery c April 2014
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were dissatisfied with the operation, and 3% of patients
regretted undergoing the operation. De Campos and col-
leagues,7 in 2003, reported a 4% regret rate in their study
of 378 patients.
In our study, we found that several factors predicted clin-
ically bothersome CH on univariate analysis: patients who
had undergone R2/R3 versus R4/R5 (P < .001), those
with multiple versus single sites of sweating at presentation
(P<.001), patients who had used oral medication to control
their hyperhidrosis preoperatively (P ¼ .022), and female
gender (P ¼ .002). On multivariate analysis, only an
R2/R3 compared with an R4/R5 interruption (P< .021)
and multiple sites of sweating at presentation (P<.037) re-
mained statistically significant. Our study, just as have
many previous publications, also found that the most com-
mon sites of CH were on the back, lower abdomen, and
groin. We also found that patients with palmar-only hyper-
hidrosis had the greatest satisfaction and lowest failure and
recurrence rates. Although many have favored an R2/R3
interruption for patients with palmar hyperhidrosis alone,
most of the patients we had treated had also had bothersome
hyperhidrosis on their axilla and feet. Thus, for the second
half of the present series, we almost exclusively used an
R4/R5 interruption.
The strengths of our report include that the same surveys
were administered yearly, only 1 surgeon performed every
operation, the response rate was high, and the median
follow-up period was long (6.5 years). We used the same
definitions and the same survey throughout the entire study
period. However, the present study also had many limita-
tions. Some of these included the inherent subjectivity of
CH and the use of self-reported surveys, which could
have led to a sampling error because of the patients who
did not respond to the survey. This might have underre-
ported the true rate of CH or clinically bothersome or severe
CH. Also we changed the operative technique during theThe Journal of Thoracic and Carstudy period and performed a different operation in the
latter aspect of the study period according to the location
of the hyperhydrosis. Finally, the bias resulting from those
who reported versus those who did not cannot be
underestimated.CONCLUSIONS
We have shown that although VATS sympathotomy can
be an effective therapy for patients with focal hyperhidrosis,
CH will be common and could be clinically bothersome in
77% of patients 1 year postoperatively. This rate
decreased over time, especially during the next 3 years. Sur-
geons should carefully counsel patients, especially those
with multiple areas of sweating about CH. Finally,
agreed-on definitions and terminology are needed to
compare series and derive the better evidence our patients
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SAPPENDIX E1. HYPERHIDROSIS—YEARLY
FOLLOW-UP QUESTIONNAIRE
Maywe contact you again in a fewmonths to see how you
are doing? No Yes
E-mail: ______________ Telephone ______________
FOLLOWING SURGERY please rate your sweating on a
scale of 10 (worst) – 0 (none):
Ex: (10) most bothersome/dripping sweat.(5) some-
what bothersome.(0) No sweating/not at all bothersome
________Right hand ________Left hand
________Right axilla (arm pit) ______Left axilla
________Face/forehead
________Right foot ________Left foot
Have you noticed sweating in any NEW areas of your
body? No Yes
Has this changed since the last time we contacted
you/your last survey? No Yes
If yes, where and how much (on a scale of 1 – 10
[worst])________________________
In retrospect, areyou glad youhad this surgery? No Yes
If no, why not? _____________________________
Are you satisfied with the results of the hyperhidrosis sur-
gery overall? No Yes
If no, why not? __________________________
Are you satisfied with the cosmetic result (scar from sur-
gery)? No Yes
Would you recommend this surgery to a friend who has
hyperhidrosis? No Yes
On a scale of 0 (no pain) – 10 (severe pain), grade any
pain you are having now related to this surgery?_____
Generally speaking, how would you rate your quality of
life (since surgery)? (circle)1163.e1 The Journal of Thoracic and Cardiovascular S1 – Excellent 2 – Very good 3 – Good 4 – Poor/infe-
rior 5 – Very poor
Using the same scale as above (1–5), how would you rate
the following activities after theVATShyperhidrosis surgery:
Writing 1 2 3 4 5urgery c April 2014Manual work 1 2 3 4 5Leisure 1 2 3 4 5Sports 1 2 3 4 5Hand shaking 1 2 3 4 5Socializing 1 2 3 4 5Grasping objects 1 2 3 4 5Social dancing 1 2 3 4 5Personal Domain – with partner/spouse.howwould you
rate your quality of life:
Holding hands 1 2 3 4 5Intimate touching 1 2 3 4 5Intimate affairs 1 2 3 4 5Emotional – Self/Others —
I am more confident now than before surgery
Very true True Not sure Not true Not at all true
People rejected me slightly
Very true True Not sure Not true Not at all true
Under Special Circumstances – Using the 1–5 scale
above, how would you rate the quality of your life:
In a closed or hot environment 1 2 3 4 5When tense or worried 1 2 3 4 5Thinking about the problem 1 2 3 4 5Before a test, meeting, or public speaking 1 2 3 4 5Wearing sandals/barefoot 1 2 3 4 5Wearing colored clothing 1 2 3 4 5Having problems at school/work 1 2 3 4 5Have you noticed a difference in your exercise ability/
capacity? No Yes
